Last week, Science Advances published a study on the CVXGA1 nasal COVID-19 vaccine Phase 1 trial. I was asked by The Defender to provide my thoughts on this recent development.
Excerpts from the art…
Keep reading with a 7-day free trial
Subscribe to Sonia Elijah investigates to keep reading this post and get 7 days of free access to the full post archives.